April 30, 2024
Women who are considered to be at average risk for breast cancer should have mammograms every other year starting at age 40 years until age 74, […]
April 30, 2024
For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
April 30, 2024
Summary Company Announcement Date: July 09, 2020 FDA Publish Date: July 24, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of methanol […]
April 30, 2024
Summary Company Announcement Date: August 30, 2023 FDA Publish Date: August 31, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Label Mix-Up Company Name: […]
April 30, 2024
WASHINGTON (Reuters) – The U.S. Justice Department on Tuesday moved to make marijuana use a less serious federal crime, taking a step to reclassify the drug […]
April 30, 2024
BUDAPEST, HUNGARY — Data on physician suicide are not readily available in many countries, and there are few educational and preventive programs to help tackle the […]
April 30, 2024
Drugs to Which FDA has Granted Pediatric Exclusivity for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies […]
April 30, 2024
Adjuvant therapy with aspirin offers no protection against recurrence or survival benefit in patients with high-risk nonmetastatic breast cancer, the results of a new phase 3 […]
April 30, 2024
TOPLINE: Mental health distress increased disproportionately among transgender and gender-nonconforming US adults between 2014 and 2021 compared with among their cisgender counterparts, a new study suggested. […]